Assessment of social functioning in depression.

Area of Science:

• Psychiatry
• Neuroscience
• Clinical Psychology

Background:

• Social functioning impairment is a critical, distinct dimension of depression.
• Traditional depression scales often overlook persistent social deficits post-treatment.
• Patient-reported outcomes are increasingly vital for assessing depression's impact.

Purpose of the Study:

• To introduce and validate the Social Adaptation Self-evaluation Scale (SASS) for assessing social functioning in depression.
• To evaluate the efficacy of antidepressant treatments on social functioning using the SASS.
• To explore the differential effects of selective NRI and SSRI on social adaptation.

Main Methods:

• Development and validation of the 21-item Social Adaptation Self-evaluation Scale (SASS) for self-assessment.
• Utilizing the SASS to compare reboxetine (selective NRI) with fluoxetine (SSRI) in depressed patients.
• Assessing changes in social interactions, global social attitude, and self-perception.

Main Results:

• The SASS is a validated, user-friendly tool sensitive to changes in social functioning.
• Reboxetine demonstrated greater efficacy than fluoxetine in improving social functioning.
• The SASS highlighted reboxetine's positive impact on patient motivation and self-perception.

Conclusions:

• The SASS is a valuable instrument for evaluating treatment response in depression.
• Selective noradrenaline reuptake inhibitors may offer advantages over SSRIs for social functioning deficits.
• Further research with the SASS can elucidate the roles of noradrenaline and serotonin in depression.